SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 54.66-1.5%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (8140)4/14/2003 4:44:57 PM
From: Biomaven  Read Replies (1) of 52153
 
Erik,

No breakdown given, so doubtless some was for psoriatic arthritis and some for straight psoriasis.

Yes indeed it is possible in the US to be reimbursed for off-label use. Remember that a large portion of chemotherapy is in fact off-label. However, health insurers have more discretion when it comes to off-label reimbursement. Actimmune is a good example - no label for IPF, but about 70% of private insurers reimburse the $50k annual cost.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News